Floor vote
Senate vote #103
On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with …
Read full descriptionHide
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
Rejected
Congress 119 · Session 2
Apr 23, 2026 · 6:51 AM
SCONRES 33